Independent fund research. Built on SEC filings.

How we research funds

ETF · Other · Advisorshares

AdvisorShares Pure US Cannabis ETF (MSOS)

Ticker MSOS · Since 2020-09-01 · · Holdings as of Jun 30, 2026

Expense ratio
0.78%$78/yr per $10k
5-yr return
−33.6%annualized
1-yr return
+23.4%as of Dec 2025
Net assets
$1.0Ball share classes
Holdings
61

Bottom line

Is MSOS a good fund? The bottom line

MSOS is a managed other ETF from Advisorshares.

It charges 0.78% — about $78 a year on every $10,000 invested, cheaper than 59% of other funds we track.

It returned +23.4% over one year, −33.6% a year over five years (as of Dec 31, 2025, per its prospectus).

With $1.0 billion in net assets and 61 holdings, its largest position is Curaleaf Holdings Inc (12.3%) and the top 10 make up 37.1% of the portfolio.

What to watch

  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What MSOS invests in

The AdvisorShares Pure US Cannabis ETF (the Fund) seeks long-term capital appreciation.

The Fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. The Fund primarily invests in exchange-listed equity securities, including common and preferred stock, of mid- and small-capitalization companies, and in total return swaps intended to provide exposure to such companies. The Fund also may invest in micro-capitalization companies. In addition to its investment in securities of companies that derive a significant portion of their revenue from the marijuana and hemp business, and in derivatives providing…

From the fund's prospectus (filed Oct 28, 2026).

MSOS performance

Fund calendar-year total returns, 2021–2025 2021: −29.5%; 2022: −72.3%; 2023: −1.8%; 2024: −46.4%; 2025: +23.4% −29.5% 2021 −72.3% 2022 −1.8% 2023 −46.4% 2024 +23.4% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
MSOS+23.4%−33.6%—
Other median+9.2%+4.9%+5.3%

Source: Fund prospectus, as of Dec 31, 2025

Full MSOS performance history →

What MSOS costs

On a $10,000 investment, MSOS's 0.78% expense ratio costs about $78 a year. The prospectus estimates $927 in total costs over 10 years (assuming 5% annual returns). The median other fund charges 0.95%.

See the full MSOS fee table →

MSOS top 10 holdings

#Holding% of fund
1Curaleaf Holdings Inc CURLD12.32%
2Trulieve Cannabis Corp TRLV9.56%
3Blackrock Treasury Trust5.78%
4Terrascend Corp TSNDF2.70%
5Marex Capital Markets Inc.2.16%
6Cantor Fitzgerald & Co.1.08%
7Morgan Stanley & Co. Llc0.94%
8Glass House Brands Inc GLAS0.93%
9Nomura Securities International, Inc.0.85%
10Cantor Fitzgerald & Co.0.78%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 37.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to MSOS

More funds like MSOS →

MSOS FAQ

What is the expense ratio of MSOS?
MSOS's expense ratio is 0.78%, which works out to about $78 a year for every $10,000 invested. The prospectus estimates total costs of $927 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MSOS a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What does MSOS hold?
MSOS's largest holdings are Curaleaf Holdings Inc (12.3%), Trulieve Cannabis Corp (9.6%), Blackrock Treasury Trust (5.8%), Terrascend Corp (2.7%), Marex Capital Markets Inc. (2.2%). It holds 61 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is MSOS's 5-year return?
MSOS returned −33.6% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Who manages MSOS?
MSOS is offered by Advisorshares through AdvisorShares Trust.